Vaccines Market by Technology (Conjugate Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Other Vaccines), Indication (Pneumococcal Disease; Influenza, Human Papilloma Virus; Meningococcal Disease; Rotavirus; Varicella; Diphtheria, Pertussis, and Tetanus (DTP); Polio; Hepatitis; Measles, Mumps, and Rubella (MMR); and Other Indications), and End Use (Pediatric Vaccines, Adult Vaccines, and Traveler Vaccines) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Vaccine is a preparation of weak or killed pathogen to stimulate the immunity process of the body. The vaccine market is a segment under the pediatric drugs market, which accounts to 80% of the pharmaceutical drugs market.
The demand for pediatric vaccines is the major driving force of the market. This is due to high birth rates in the developing countries that accounted to 97% in 2012. The major restraint is the side effects produced by the vaccines.
The opportunities of this market are the growing DNA vaccine market, which is easy to develop, low cost and few side effects. The challenges faced by this market are the development of vaccines.
The vaccines are based on live organisms that have inherent variability. A small variation in the production process will significantly alter the biological property of the product.
The key players profiled in this report are: Abbott laboratories, Baxter International INC. GlaxoSmithKline PLC, Merck & CO. INC., Novartis AG, PFIZER, LG Life Sciences, Nippon Biologicals INC., Advaxis, Panacea biotec ltd.
KEY BENEFITS The report analyzes the vaccines market which is a combination of pediatric and adult vaccine market.
The report provides in-depth analysis about types, applications and geography of the vaccine market
The report evaluates the key factors that prove to be drivers and restraints for the market
The report analyzes the vaccine market based on the various segments to forecast growth till 2020.
The report analyzes the market factors in various geographic regions to understand business opportunities
Global vaccines market by, Applications Therapeutic vaccines
Based on diseases
Adult booster vaccines
Travel related and other endemic diseases
HPV (human papillomavirus) disease
Global vaccines market by, Geography North America
KEY AUDIENCES Government health organization
Manufacturers of vaccines
Our reports have been used by over 10K customers, including:
Executive Summary The mRNA technology finds its applications in many diseases including the Covid-19 vaccine. The market for mRNA is mostly driven by the Covid-19 vaccine besides its major usage in cancer therapies. With the mutation of the coronavirus and possible spread of variants of the virus, the mRNA companies are...
This study ’s Healthcare and Life Sciences team provides critical insights into the US COVID-19 vaccines and therapeutics market, including developing vaccines, supply chain considerations, and requirements to manage distribution. The study also identifies actionable and profitable growth opportunities for industry participants.
“Genital Herpes – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Genital Herpes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...
“Genital herpes - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Genital herpes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...
Community Acquired Pneumonia (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Community Acquired Pneumonia - Drugs in Development, 2021, provides an overview of the Community Acquired Pneumonia (Infectious Disease) pipeline...
Global mRNA Vaccines and Therapeutics Market for COVID-19 Vaccines and Non-COVID-19 Vaccines to Reach $28.92 Billion and $1.69 Billion by 2025 and 2031, Respectively; BIS Research Study Market Report Coverage - mRNA Vaccines and Therapeutics Market Segmentation • Application – COVID-19...
125 pages •
By Global Industry Analysts
• Apr 2021
- Global Clostridium Difficile Treatment Market to Reach $1.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Clostridium Difficile Treatment estimated at US$878.9 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 5.1% over the...
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
175 pages •
By The Business Research Company
• Jul 2021
Major players in the gynecology drugs market are Hoffmann-La Roche Ltd., Pfizer Inc., Merck & Co. Inc., Allergan, AstraZeneca, Bayer AG, AbbVie, TherapeuticsMD Inc., Lupin Pharmaceuticals Inc., Ferring Holding SA, Johnson & Johnson, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., and Sanofi. The global gynecology drugs market...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.